Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer
Work
Year: 2022
Type: article
Abstract: Cancer immunotherapy has emerged as a promising strategy against triple-negative breast cancer (TNBC). One of the immunosuppressive pathways involves programmed cell death-1 (PD-1) and programmed cell... more
Source: Chinese Medical Journal
Cites: 44
Cited by: 9
Related to: 10
FWCI: 1.48
Citation percentile (by year/subfield): 81.48
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,000